FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hugo Murua Escobar

Research Profile

Living Beings

Dogs

Disorders

Procedures

Chemicals & Drugs

Anatomy

Mammalian Chromosomes

Phenomena

Blotting, Northern

Physiology

Concepts & Ideas

Molecular Sequence Data

Devices

Bacterial Artificial Chromosomes

Co-author Network

Publications

TOP 3
Maria Carolina Duran; Karsten Feige; Jessika-M V Müller; Ingo Nolte; Saskia Willenbrock; Hugo Murua Escobar
Establishment and Evaluation of a Bead-based Luminex Assay Allowing Simultaneous Quantification of Equine IL-12 and IFN-γ.
M C Durán; K Feige; I Nolte; S Willenbrock; R Carlson; Hugo Murua Escobar
Enhanced protocol for CD14+ cell enrichment from equine peripheral blood via anti-human CD14 mAb and automated magnetic activated cell sorting.
Siegfried Wagner; Saskia Willenbrock; Ingo Nolte; Hugo Murua Escobar
Comparison of non-coding RNAs in human and canine cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hugo Murua Escobar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maria Carolina Duran; Karsten Feige; Jessika-M V Müller; Ingo Nolte; Saskia Willenbrock; Hugo Murua Escobar
Establishment and Evaluation of a Bead-based Luminex Assay Allowing Simultaneous Quantification of Equine IL-12 and IFN-γ.
Anticancer research 2013;33(4):1325-36.
2013: M C Durán; K Feige; I Nolte; S Willenbrock; R Carlson; Hugo Murua Escobar
Enhanced protocol for CD14+ cell enrichment from equine peripheral blood via anti-human CD14 mAb and automated magnetic activated cell sorting.
Equine veterinary journal 2013;45(2):249-53.
2013: Siegfried Wagner; Saskia Willenbrock; Ingo Nolte; Hugo Murua Escobar
Comparison of non-coding RNAs in human and canine cancer.
Frontiers in genetics 2013;4():46.
2013: Dag Heinemann; Regina Carlson; Stefan Kalies; Heiko Meyer; Hugo Murua Escobar; Tammo Ripken; Maximilian Schieck; Markus Schomaker; Alexander Heisterkamp
Gold nanoparticle mediated laser transfection for efficient siRNA mediated gene knock down.
PloS one 2013;8(3):e58604.
2013: Katharina Anna Sterenczak; Ingo Nolte; Hugo Murua Escobar
RAGE splicing variants in mammals.
Methods in molecular biology (Clifton, N.J.) 2013;963():265-76.
2012: Nicola Reimann-Berg; Hugo Murua Escobar; Ingo Nolte
Relevance of chromosome 13 aberrations in canine tumours.
Tierärztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 2012;40(4):267-70.
2012: Katharina A Sterenczak; Patrick Wefstaedt; Saskia Willenbrock; Jörn Bullerdiek; Martina Dorsch; Silke Glage; Hans Hedrich; Martin Meier; Matthias Meyer; Hugo Murua Escobar; Ingo Nolte
Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
BMC cancer 2012;12():284.
2012: Nicola Reimann-Berg; J Bullerdiek; Hugo Murua Escobar; Ingo Nolte
Chromosome analyses in dogs.
Tierärztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 2012;40(3):191-6.
2012: A A Ismail; Hugo Murua Escobar; Ingo Nolte; M T Samy; K A Sterenczak; S Wagner; A M Abd El-Aal; S Willenbrock; Patrick Wefstaedt
Effects of high-mobility group a protein application on canine adipose-derived mesenchymal stem cells in vitro.
Veterinary medicine international 2012;2012():752083.
2012: M H Müller; J Bullerdiek; Nicola Reimann-Berg; Hugo Murua Escobar
Genetic characterization of dogs via chromosomal analysis and array-based comparative genomic hybridization (aCGH).
Tierärztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 2012;40(1):55-8.
2011: J Fitting; Christian Junghanss; D Killian; S Lange; Hugo Murua Escobar; I Nolte; S Barth; S Willenbrock; M K Tur
Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology.
Veterinary and comparative oncology 2011;9(3):183-95.
2011: Katharina A Sterenczak; Sven Kleinschmidt; Patrick Wefstaedt; Nina Eberle; Marion Hewicker-Trautwein; Jörn Bullerdiek; Ingo Nolte; Hugo Murua Escobar
Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis).
Anticancer research 2011;31(5):1541-8.
2011: María Carolina Durán; Karsten Feige; Arianna Maiolini; Jessika-M V Müller; Annette Barchanski; Stephan Barcikowski; Ingo Nolte; Jan T Soller; Saskia Willenbrock; Hugo Murua Escobar
Comparison of nanoparticle-mediated transfection methods for DNA expression plasmids: efficiency and cytotoxicity.
Journal of nanobiotechnology 2011;9():47.
2011: Nicola Reimann-Berg; S Willenbrock; Nina Eberle; Y Kiefer; Reinhard Mischke; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-Stimulated canine B-Cell lymphoma cells reveals the loss of one X Chromosome as the sole abnormality.
Cytogenetic and genome research 2011;135(1):79-82.
2011: Nicola Reimann-Berg; S Willenbrock; Hugo Murua Escobar; Nina Eberle; Ingo Gerhauser; Reinhard Mischke; Jörn Bullerdiek; Ingo Nolte
Two new cases of polysomy 13 in canine prostate cancer.
Cytogenetic and genome research 2011;132(1-2):16-21.
2010: Katharina A Sterenczak; Alexa E Joetzke; Saskia Willenbrock; Nina Eberle; Sandra Lange; Christian Junghanss; Ingo Nolte; Jörn Bullerdiek; Daniela Simon; Hugo Murua Escobar
High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma.
Anticancer research 2010;30(12):5043-8.
2010: A E Joetzke; K A Sterenczak; Nina Eberle; S Wagner; Jan T Soller; Ingo Nolte; Jörn Bullerdiek; Hugo Murua Escobar; D Simon
Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
Veterinary and comparative oncology 2010;8(2):87-95.
2009: Katharina A Sterenczak; Saskia Willenbrock; Matthias Barann; Markus Klemke; Jan T Soller; Nina Eberle; Ingo Nolte; Jörn Bullerdiek; Hugo Murua Escobar
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Gene 2009;434(1-2):35-42.
2009: Andreas Richter; Gregor Hauschild; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Application of high-mobility-group-A proteins increases the proliferative activity of chondrocytes in vitro.
Tissue engineering. Part A 2009;15(3):473-7.
2009: Svea Petersen; Jan T Soller; Siegfried Wagner; Andreas Richter; Jörn Bullerdiek; Ingo Nolte; Stephan Barcikowski; Hugo Murua Escobar
Co-transfection of plasmid DNA and laser-generated gold nanoparticles does not disturb the bioactivity of GFP-HMGB1 fusion protein.
Journal of nanobiotechnology 2009;7():6.
2008: Simone Altmann; S Lange; J Pommerencke; Hugo Murua Escobar; J Bullerdiek; I Nolte; Mathias Freund; Christian Junghanss
High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity.
Veterinary immunology and immunopathology 2008;126(3-4):367-72.
2008: Nicola Reimann-Berg; Hugo Murua Escobar; Ingo Nolte; Jörn Bullerdiek
Testicular tumor in an XXY dog.
Cancer genetics and cytogenetics 2008;183(2):114-6.
2008: J Baumgart; W Bintig; Anaclet Ngezahayo; S Willenbrock; Hugo Murua Escobar; Wolfgang Ertmer; Holger Lubatschowski; Alexander Heisterkamp
Quantified femtosecond laser based opto-perforation of living GFSHR-17 and MTH53 a cells.
Optics express 2008;16(5):3021-31.
2008: Melani A M Fork; Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Saskia Willenbrock; Susanne Winkler; Martina Dorsch; Nicola Reimann-Berg; Hans J Hedrich; Jörn Bullerdiek; Ingo Nolte
Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.
BMC cancer 2008;8():240.
2008: Claudia Beuing; Jan T Soller; Michaela Muth; Sigfried Wagner; Gaudenz Dolf; Claude Schelling; Andreas Richter; Saskia Willenbrock; Nicola Reimann-Berg; Susanne Winkler; Ingo Nolte; Jorn Bullerdiek; Hugo Murua Escobar
Genomic characterisation, chromosomal assignment and in vivo localisation of the canine high mobility group A1 (HMGA1) gene.
BMC genetics 2008;9():49.
2008: Jan T Soller; Claudia Beuing; Susanne Winkler; Nicola Reimann-Berg; Norbert Drieschner; Gaudenz Dolf; Claude Schelling; Ingo Nolte; Hugo Murua Escobar; Jörn Bullerdiek
Chromosomal assignment of canine THADA gene to CFA 10q25.
Molecular cytogenetics 2008;1():11.
2007: Britta Meyer; D Krisponeit; C Junghanss; Hugo Murua Escobar; Jörn Bullerdiek
Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.
Leukemia & lymphoma 2007;48(10):2008-13.
2007: Susanne Winkler; Hugo Murua Escobar; Britta Meyer; Daniela Simon; Nina Eberle; Wolfgang Baumgartner; Siegfried Loeschke; Ingo Nolte; Jörn Bullerdiek
HMGA2 expression in a canine model of prostate cancer.
Cancer genetics and cytogenetics 2007;177(2):98-102.
2007: Jan T Soller; Hugo Murua Escobar; Saskia Willenbrock; Miriam Janssen; Nina Eberle; Jörn Bullerdiek; Ingo Nolte
Comparison of the human and canine cytokines IL-1(alpha/beta) and TNF-alpha to orthologous other mammalians.
The Journal of heredity 2007;98(5):485-90.
2007: J Jensen; D Simon; Hugo Murua Escobar; H M Escobar; Jan T Soller; Jörn Bullerdiek; Pamela Beelitz; Kurt Pfister; Ingo Nolte
Anaplasma phagocytophilum in dogs in Germany.
Zoonoses and public health 2007;54(2):94-101.
2006: Jan T Soller; Hugo Murua Escobar; Miriam Janssen; Melani Fork; Jörn Bullerdiek; Ingo Nolte
Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis.
Anticancer research 2006;26(5A):3417-20.
2006: Susanne Winkler; Nicola Reimann-Berg; Hugo Murua Escobar; Siegfried Loeschke; Nina Eberle; Ruth Höinghaus; Ingo Nolte; Jörn Bullerdiek
Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer.
Cancer genetics and cytogenetics 2006;169(2):154-8.
2006: Hugo Murua Escobar; Jan T Soller; Katharina A Sterenczak; Jan D Sperveslage; Claudia Schlueter; Birgit Burchardt; Nina Eberle; Melanie Fork; Rolf Nimzyk; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Cloning and characterization of the canine receptor for advanced glycation end products.
Gene 2006;369():45-52.
2005: Susanne Winkler; Hugo Murua Escobar; Nicola Reimann-Berg; Jörn Bullerdiek; Ingo Nolte
Cytogenetic investigations in four canine lymphomas.
Anticancer research 2005;25(6B):3995-8.
2005: Sven Hauke; Silke Leopold; Claudia Schlueter; Aljoscha M Flohr; Hugo Murua Escobar; Piere Rogalla; Jörn Bullerdiek
Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene.
Biochimica et biophysica acta 2005;1729(1):24-31.
2005: Andreas Richter; Hugo Murua Escobar; Kathrin Günther; Jan T Soller; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
RAS gene hot-spot mutations in canine neoplasias.
The Journal of heredity 2005;96(7):764-5.
2005: Susanne Winkler; Hugo Murua Escobar; Nina Eberle; Nicola Reimann-Berg; Ingo Nolte; Jörn Bullerdiek
Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.
The Journal of heredity 2005;96(7):782-5.
2005: Hugo Murua Escobar; Jan T Soller; Andreas Richter; Britta Meyer; Susanne Winkler; Jörn Bullerdiek; Ingo Nolte
"Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
The Journal of heredity 2005;96(7):777-81.
2004: J Meyer; Hugo Murua Escobar; S Bartnitzke; Claude Schelling; Gaudenz Dolf; Ingo Nolte; Jörn Bullerdiek
The FAS-activated serine/threonine kinase gene maps to canine chromosome 16.
Animal genetics 2004;35(6):497.
2004: B Meyer; Hugo Murua Escobar; Susanne Winkler; Gaudenz Dolf; Claude Schelling; Jörn Bullerdiek; Ingo Nolte
Molecular characterization and mapping of the canine cyclin D1 (CCND1) gene.
Animal genetics 2004;35(5):413.
2004: Hugo Murua Escobar; Kathrin Günther; Andreas Richter; Jan T Soller; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
Anticancer research 2004;24(5A):3027-8.
2004: Andreas Richter; Hugo Murua Escobar; Kathrin Günther; B Meyer; Susanne Winkler; Gaudenz Dolf; Claude Schelling; Ingo Nolte; Jörn Bullerdiek
The canine NRAS gene maps to CFA 17.
Animal genetics 2004;35(4):355-6.
2004: Hugo Murua Escobar; J Meyer; Susanne Winkler; Claude Schelling; Gaudenz Dolf; Ingo Nolte; Jörn Bullerdiek
The protein kinase B, gamma (AKT3) gene maps to canine chromosome 7.
Animal genetics 2004;35(4):354-5.
2004: Susanne Winkler; Hugo Murua Escobar; Kathrin Günther; Andreas Richter; Gaudenz Dolf; Claude Schelling; Jörn Bullerdiek; Ingo Nolte
The canine KRAS2 gene maps to chromosome 22.
Animal genetics 2004;35(4):350-1.
2004: Maren Meiboom; Hugo Murua Escobar; Susanne Winkler; Ingo Nolte; Jörn Bullerdiek
Molecular characterization and mapping of the canine KRAB zinc finger gene ZNF331.
Animal genetics 2004;35(3):262-3.
2004: Hugo Murua Escobar; Jan T Soller; Andreas Richter; Britta Meyer; Susanne Winkler; Aljoscha M Flohr; Ingo Nolte; Jörn Bullerdiek
The canine HMGA1.
Gene 2004;330():93-9.
2004: Britta Meyer; Hugo Murua Escobar; Sven Hauke; Andreas Richter; Susanne Winkler; Piere Rogalla; Aljoscha M Flohr; Jörn Bullerdiek; Ingo Nolte
Expression pattern of the HMGB1 gene in sarcomas of the dog.
Anticancer research 2004;24(2B):707-10.
2004: S E C Santos; Hugo Murua Escobar; L H Sider; S Winkler; Sergio Aoki; Marcella Pecora Milazzotto; F Campagnari; C I Vannucchi; J Bullerdiek; I Nolte; José Fernando Garcia
DNA sequence, polymorphism, and mapping of luteinizing hormone receptor fragment (LHCGR) gene in Great Dane dogs.
Animal genetics 2004;35(1):74-5.
2004: Torsten Goldmann; Aljoscha M Flohr; Hugo Murua Escobar; Bernhard Gerstmayer; Uwe Janssen; Andreas Bosio; Siegfried Loeschke; Ekkehard Vollmer; Jörn Bullerdiek
The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues.
Pathology, research and practice 2004;200(7-8):511-5.
2003: Volkhard Rippe; Norbert Drieschner; Maren Meiboom; Hugo Murua Escobar; Ulrich Bonk; Gazanfer Belge; Jörn Bullerdiek
Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Oncogene 2003;22(38):6111-4.
2003: K Becker; Hugo Murua Escobar; Andreas Richter; B Meyer; Ingo Nolte; Jörn Bullerdiek
The canine HMGA1 gene maps to CFA 23.
Animal genetics 2003;34(1):68-9.
2003: Maren Meiboom; Hugo Murua Escobar; F Pentimalli; Alfredo Fusco; Gazanfer Belge; Jörn Bullerdiek
A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas.
Cytogenetic and genome research 2003;101(2):113-7.
2003: Hugo Murua Escobar; Britta Meyer; Andreas Richter; K Becker; Aljoscha M Flohr; Jörn Bullerdiek; Ingo Nolte
Molecular characterization of the canine HMGB1.
Cytogenetic and genome research 2003;101(1):33-8.
2001: Hugo Murua Escobar; K Becker; Jörn Bullerdiek; I Nolte
The canine ERBB2 gene maps to a chromosome region frequently affected by aberrations in tumors of the dog (Canis familiaris).
Cytogenetics and cell genetics 2001;94(3-4):194-5.